drugset / Trial / NCT01230125
Mapracorat Ophthalmic Suspension for the Treatment of Ocular Inflammation Following Cataract Surgery
RandomizedParallel-groupDouble-blindTreatment
Summary
The objective of this clinical study is to compare the safety and efficacy of Mapracorat Ophthalmic Suspension, 3% to vehicle for the treatment of postoperative inflammation and pain following cataract surgery.
Timeline
- Start
- 2010-11
- Primary completion
- 2011-06
- Completion
- 2011-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Mapracorat | Small molecule | 3 % | Other |